Marshall Wace’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
49,077
+18,732
| +62% | +$422K | ﹤0.01% | 1682 |
|
|
2025
Q1 | $849K | Buy |
+30,345
| New | +$849K | ﹤0.01% | 1752 |
|
|
2023
Q2 | – | Sell |
-28,329
| Closed | -$2.22M | – | 2613 |
|
|
2023
Q1 | $2.22M | Sell |
28,329
-1,571
| -5% | -$123K | ﹤0.01% | 1127 |
|
|
2022
Q4 | $2.49M | Sell |
29,900
-615
| -2% | -$51.2K | 0.01% | 1282 |
|
|
2022
Q3 | $2.81M | Sell |
30,515
-1,106
| -3% | -$102K | 0.01% | 1432 |
|
|
2022
Q2 | $4.73M | Sell |
31,621
-847
| -3% | -$127K | 0.01% | 1229 |
|
|
2022
Q1 | $7.87M | Buy |
32,468
+4,921
| +18% | +$1.19M | 0.01% | 979 |
|
|
2021
Q4 | $8.33M | Buy |
27,547
+24,804
| +904% | +$7.5M | 0.02% | 926 |
|
|
2021
Q3 | $1.13M | Buy |
2,743
+2,488
| +976% | +$1.03M | ﹤0.01% | 1497 |
|
|
2021
Q2 | $78K | Buy |
+255
| New | +$78K | ﹤0.01% | 2027 |
|
|
2020
Q1 | – | Sell |
-592
| Closed | -$171K | – | 2081 |
|
|
2019
Q4 | $171K | Buy |
+592
| New | +$171K | ﹤0.01% | 1326 |
|
|
2018
Q4 | – | Sell |
-2,013
| Closed | -$902K | – | 1845 |
|
|
2018
Q3 | $902K | Buy |
2,013
+1,721
| +589% | +$771K | 0.01% | 832 |
|
|
2018
Q2 | $118K | Buy |
+292
| New | +$118K | ﹤0.01% | 671 |
|